Monographie - Temocilline

Last update :
19/11/2024

Temocilline

Chemical structure

Tradename

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Negaban

Belgium, France, Great Britain, Luxembourg

References : Temocilline

	Type	Publication
2231	Journal	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2275	Journal	Craig Dyar S, Notari RE. Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers. Int J Pharm 1998 ; 173: 221-232.
2296	Manufacturer	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
3154	Journal	Carryn S, Couwenbergh N, Tulkens PM Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients. J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.
3255	Journal	Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L. Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment Ann Pharm Fr 2011 ; 69, 6 : 296-301.
3385	Journal	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3520	Manufacturer	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Manufacturer	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3549	Manufacturer	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Manufacturer	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Manufacturer	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
4470	Journal	Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P. Continuous versus intermittent infusion of temocillin in intensive care unit patient. Critical care 2005 ; 9(Suppl 1) P37
4634	Journal	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458

Mentions Légales